3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
48
Squamous Cell Carcinoma of Head and Neck
23
Lung Neoplasms
22
Oropharyngeal Neoplasms
13
Urinary Bladder Neoplasms
12
Nasopharyngeal Carcinoma
12
Carcinoma
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Biliary Tract Neoplasms
8
Uterine Cervical Neoplasms
7
Head and Neck Neoplasms
7
Cholangiocarcinoma
7
Pancreatic Neoplasms
6
Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Colorectal Neoplasms
6
Small Cell Lung Carcinoma
5
Neoplasm Metastasis
5
Mouth Neoplasms
5
Stomach Neoplasms
4
Laryngeal Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Squamous Cell
4
Ovarian Neoplasms
3
Neoplasms by Site
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Gallbladder Neoplasms
3
Interventions
durvalumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Cancer Unresectable
×
Cisplatin
×
30 days
×
Clear all
NCT06591650
2026-05-14
GCND
Fudan University
Phase 2
Recruiting
33 enrolled